Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer

Clinical trial NCT01215799 · COMPLETED

Trial details

NCT number: NCT01215799
Sponsor: CytRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2010-08-01
Primary completion: 2011-09-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.